News

FDA Breakthrough Device using Optical Spectroscopy was Found to Significantly Increase Physicians’ Detection of Skin Cancer

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., the pioneer of the first point-and-click skin cancer detection device for primary care physicians, announces the publication…

2 years ago

Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer

Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer to Propel Innovations in Complex Multisystem Disorder CareSALT…

2 years ago

BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees

VINIA Superfood Coffee will be a unique disruptor in the $6B US coffee pod marketFirst of three Major "VINIA Inside"…

2 years ago

Justera Introduces K-Beauty Online Store

Toronto, Ontario--(Newsfile Corp. - December 13, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company")…

2 years ago

Lynx.MD and Baptist Health Innovations Collaborate to Advance Medical Research and Development

Initiative enhances Baptist Health South Florida's efforts in medical innovation for advanced research and collaborative development.PALO ALTO, CA / ACCESSWIRE…

2 years ago

Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer

Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer to Propel Innovations in Complex Multisystem Disorder CareSALT…

2 years ago

SELLAS to Host Corporate Update Webinar on January 3, 2024 at 8:30 am ET

NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a…

2 years ago

Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com

Peter Croden, CrodenHealth Chairman, previously executive with Pharmacia & Upjohn (Pfizer), Upjohn Canada, Upjohn Global Animal Health, NephRx, and Parnell…

2 years ago

Protagonist Earns $10 Million Payment for Achievement of Clinical Milestone in Phase 2b ANTHEM-UC Study of JNJ-2113 in Adults with Moderately to Severely Active Ulcerative Colitis

NEWARK, CA / ACCESSWIRE / December 13, 2023 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced it has…

2 years ago

Research for the Treatment of a ‘Black Sheep’ Cancer Moves to Human Clinical Trials

With $3.5 million in funding from the GI Research Foundation, a team at the MD Anderson Cancer Center explores a…

2 years ago